| AES | Advanced Expert System |
| β-LI | beta-lactamase inhibitor |
| AMR | Antimicrobial resistance |
| CLSI | Institute for Clinical and Laboratory Standards |
| CVC | Central venous catheter |
| CRKP | Carbapenem-resistant Klebsiella pneumoniae |
| DSB | Dry surface biofilms |
| EPS | Extracellular polymeric substances |
| ESLB | Extended spectrum beta-lactamase |
| GLASS | Global Antimicrobial Resistance and Use Surveillance System |
| ICU | Intensive care unit |
| KPC-KP | Carbapenemase-producing Klebsiella pneumoniae |
| MDR | Multidrug-resistant |
| MIC | Minimum inhibitory concentration |
| MIU | Motility indole urea |
| MRSA | Methicillin-resistant Staphylococcus aureus |
| PDR | Pandrug-resistant |
| PVC | Polyvinil chloride |
| R | Resistance |
| S | Sensitivity |
| TMP/SMX | Trimethoprim and Sulfamethoxazole |
| TSI | Triple sugar iron |
| VAP | Ventilator-associated pneumonia |
| VISA | Vancomycin-intermediate Staphylococcus aureus |
| VRE | Vancomycin-resistant Enterococcus faecium |
| VRSA | Vancomycin-resistant Staphylococcus aureus |
| WHO | World Health Organization |
| XDR | Extensively drug-resistant |